These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35932228)

  • 21. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
    Lue C; Tarkowski A; Mestecky J
    J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations.
    Park S; Nahm MH
    Infect Immun; 2011 Jan; 79(1):314-20. PubMed ID: 21041499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
    Snippe H; van Houte AJ; van Dam JE; De Reuver MJ; Jansze M; Willers JM
    Infect Immun; 1983 Jun; 40(3):856-61. PubMed ID: 6852923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
    McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
    J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Pneumococcal Protein-Polysaccharide Conjugate Vaccine Based on Biotin-Streptavidin.
    Guo M; Guo X; Zhang C; Zhu S; Zhang Y; Gu T; Kong W; Wu Y
    Infect Immun; 2022 Jan; 90(1):e0035221. PubMed ID: 34694917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.
    Talesnik E; Vial PA; Labarca J; Méndez C; Soza X
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):471-7. PubMed ID: 9859960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3.
    Babb R; Doyle CR; Pirofski LA
    Microbiol Spectr; 2021 Dec; 9(3):e0144621. PubMed ID: 34756090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aging promotes B-1b cell responses to native, but not protein-conjugated, pneumococcal polysaccharides: implications for vaccine protection in older adults.
    Haas KM; Blevins MW; High KP; Pang B; Swords WE; Yammani RD
    J Infect Dis; 2014 Jan; 209(1):87-97. PubMed ID: 23964109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.
    Tian H; Weber S; Thorkildson P; Kozel TR; Pirofski LA
    Infect Immun; 2009 Apr; 77(4):1502-13. PubMed ID: 19168739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria.
    Richter MY; Jakobsen H; Birgisdottir A; Haeuw JF; Power UF; Del Giudice G; Bartoloni A; Jonsdottir I
    Infect Immun; 2004 Jan; 72(1):187-95. PubMed ID: 14688096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.
    Jakobsen H; Schulz D; Pizza M; Rappuoli R; Jónsdóttir I
    Infect Immun; 1999 Nov; 67(11):5892-7. PubMed ID: 10531245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.
    Mold C; Rodic-Polic B; Du Clos TW
    J Immunol; 2002 Jun; 168(12):6375-81. PubMed ID: 12055255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical relevance of IgM and IgA anti-pneumococcal polysaccharide ELISA assays in patients with suspected antibody deficiency.
    Janssen LMA; Heron M; Murk JL; Leenders ACAP; Rijkers GT; de Vries E
    Clin Exp Immunol; 2021 Aug; 205(2):213-221. PubMed ID: 33877708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and delivery of
    Su H; Liu Q; Bian X; Wang S; Curtiss R; Kong Q
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33380455
    [No Abstract]   [Full Text] [Related]  

  • 35. Terminal Deoxynucleotidyl Transferase Is Not Required for Antibody Response to Polysaccharide Vaccines against Streptococcus pneumoniae and Salmonella enterica Serovar Typhi.
    Belde V; Cravens MP; Gulandijany D; Walker JA; Palomo-Caturla I; Alugupalli AS; Sandilya VK; Mahmoud T; Bäumler AJ; Kearney JF; Alugupalli KR
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29967094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic analysis of pneumococcal polysaccharide-specific B cells.
    Khaskhely N; Mosakowski J; Thompson RS; Khuder S; Smithson SL; Westerink MA
    J Immunol; 2012 Mar; 188(5):2455-63. PubMed ID: 22271652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine.
    Licciardi PV; Toh ZQ; Clutterbuck EA; Balloch A; Marimla RA; Tikkanen L; Lamb KE; Bright KJ; Rabuatoka U; Tikoduadua L; Boelsen LK; Dunne EM; Satzke C; Cheung YB; Pollard AJ; Russell FM; Mulholland EK
    J Allergy Clin Immunol; 2016 Jun; 137(6):1772-1779.e11. PubMed ID: 26825000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
    Chu RS; McCool T; Greenspan NS; Schreiber JR; Harding CV
    Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SLy2-deficiency promotes B-1 cell immunity and triggers enhanced production of IgM and IgG
    Jaufmann J; Tümen L; Schmitt F; Schäll D; von Holleben M; Beer-Hammer S
    Immun Inflamm Dis; 2020 Dec; 8(4):736-752. PubMed ID: 33098380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo.
    Fabrizio K; Manix C; Guimaraes AJ; Nosanchuk JD; Pirofski LA
    Clin Vaccine Immunol; 2010 May; 17(5):713-21. PubMed ID: 20200186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.